Evidence map›Paper›PMID 28561034›Full record

ArticleNature communications2017

A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks.

Fabio Iannelli, Alessandro Galbiati, Ilaria Capozzo, Quan Nguyen, Brian Magnuson, Flavia Michelini, Giuseppina D'Alessandro, Matteo Cabrini, Marco Roncador, Sofia Francia and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 132 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Fabio IannelliIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Alessandro GalbiatiIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Ilaria CapozzoIGM (Istituto di Genetica Molecolare)-CNR (Consiglio Nazionale delle Ricerche). Via Abbiategrasso 207, 27100 Pavia, Italy.
Quan NguyenDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Brian MagnusonDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Flavia MicheliniIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Giuseppina D'AlessandroIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Matteo CabriniIGM (Istituto di Genetica Molecolare)-CNR (Consiglio Nazionale delle Ricerche). Via Abbiategrasso 207, 27100 Pavia, Italy.
Marco RoncadorIGM (Istituto di Genetica Molecolare)-CNR (Consiglio Nazionale delle Ricerche). Via Abbiategrasso 207, 27100 Pavia, Italy.
Sofia FranciaIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
Nicola CrosettoScience for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden.
Mats LjungmanDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Piero CarninciDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.ORCID 0000-0001-7202-7243
Fabrizio d'Adda di FagagnaIFOM, The FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy.
IFOM · ITIstituto di Genetica Molecolare · ITUniversity of Michigan · USScience for Life Laboratory · SE

Funding

European Research Council 322726Worldwide Cancer Research 14-1331
6 · The paper itself

Abstract

Of the many types of DNA damage, DNA double-strand breaks (DSBs) are probably the most deleterious. Mounting evidence points to an intricate relationship between DSBs and transcription. A cell system in which the impact on transcription can be investigated at precisely mapped genomic DSBs is essential to study this relationship. Here in a human cell line, we map genome-wide and at high resolution the DSBs induced by a restriction enzyme, and we characterize their impact on gene expression by four independent approaches by monitoring steady-state RNA levels, rates of RNA synthesis, transcription initiation and RNA polymerase II elongation. We consistently observe transcriptional repression in proximity to DSBs. Downregulation of transcription depends on ATM kinase activity and on the distance from the DSB. Our study couples for the first time, to the best of our knowledge, high-resolution mapping of DSBs with multilayered transcriptomics to dissect the events shaping gene expression after DSB induction at multiple endogenous sites.

Indexed as

DNA Breaks, Double-StrandedGene Expression ProfilingGene Expression RegulationAnimalsAtaxia Telangiectasia Mutated ProteinsCell Line, TumorCluster AnalysisDNADNA-Binding ProteinsDNA DamageDNA RepairGenome, HumanHumansMiceNIH 3T3 CellsPhosphorylationAtaxia Telangiectasia Mutated ProteinsATM protein, humanDNADNA-Binding Proteins

Identifiers

PMID28561034
PMCPMC5499205
OpenAlexW2617370271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.